MX9700833A - Virus de herpes recombinante de pavo y usos del mismo. - Google Patents

Virus de herpes recombinante de pavo y usos del mismo.

Info

Publication number
MX9700833A
MX9700833A MX9700833A MX9700833A MX9700833A MX 9700833 A MX9700833 A MX 9700833A MX 9700833 A MX9700833 A MX 9700833A MX 9700833 A MX9700833 A MX 9700833A MX 9700833 A MX9700833 A MX 9700833A
Authority
MX
Mexico
Prior art keywords
turkeys
herpesvirus
provides
recombinant herpesvirus
region
Prior art date
Application number
MX9700833A
Other languages
English (en)
Inventor
Mark D Cochran
David E Junker
Martha A Wild
Philip A Singer
Original Assignee
Syntro Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/288,065 external-priority patent/US5961982A/en
Application filed by Syntro Corp filed Critical Syntro Corp
Publication of MX9700833A publication Critical patent/MX9700833A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Esta invencion proporciona un virus de herpes recombinante de pavos que comprende una secuencia DNA ajena codificando una citosina insertada dentro de una region de insercion que comprende el sitio XhoI dentro de un fragmento EcoR1 #9 de un virus herpes de genoma viral de pavo, y la secuencia DNA ajena codificando una citosina la cual es capaz de ser expresada en una célula anfitriona infectada con el virus herpes de pavo. Esta invencion proporciona un virus herpes recombinante de la quimera de virus de enfermedad de Marek-pavo que comprende un virus herpes de region de genoma viral largo unico de pavo y una region corta unica de virus de enfermedad de Marek. Finalmente, esta invencion proporciona vectores de homología para producir un virus de herpes recombinante de pavos, células anfitrionas y vacunas y métodos de inmunizacion.
MX9700833A 1994-08-09 1995-08-09 Virus de herpes recombinante de pavo y usos del mismo. MX9700833A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/288,065 US5961982A (en) 1985-09-06 1994-08-09 Recombinant herpesvirus of turkeys and uses thereof
US08/362,240 US5965138A (en) 1985-09-06 1994-12-22 Recombinant chimeric virus and uses thereof
PCT/US1995/010245 WO1996005291A1 (en) 1994-08-09 1995-08-09 Recombinant herpesvirus of turkeys and uses thereof

Publications (1)

Publication Number Publication Date
MX9700833A true MX9700833A (es) 1997-06-28

Family

ID=26964815

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9700833A MX9700833A (es) 1994-08-09 1995-08-09 Virus de herpes recombinante de pavo y usos del mismo.

Country Status (11)

Country Link
US (1) US5965138A (es)
EP (2) EP0776361B1 (es)
JP (2) JP3756950B2 (es)
AT (2) ATE350467T1 (es)
AU (1) AU711815C (es)
CA (1) CA2196570C (es)
DE (2) DE69535359T2 (es)
DK (1) DK0776361T3 (es)
ES (1) ES2278382T3 (es)
MX (1) MX9700833A (es)
WO (1) WO1996005291A1 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3292371B2 (ja) * 1988-09-13 2002-06-17 メリアル ウイルスのヌクレオチド配列
US6183753B1 (en) * 1994-08-09 2001-02-06 Schering-Plough Veterinary Corp. Recombinant chimeric virus and uses thereof
US6913751B2 (en) * 1992-06-12 2005-07-05 Schering-Plough Veterinary Corporation Recombinant avian herpesvirus useful in vaccine production
US6875856B2 (en) 1993-09-24 2005-04-05 Syntro Corporation Recombinant infectious laryngotracheitis virus and uses thereof
FR2728794B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin recombinant aviaire a base de virus herpes aviaire, notamment contre la maladie de gumboro
FR2728795B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire
DE69836557T2 (de) * 1997-10-03 2007-09-20 Zeon Corp. Rekombinanten des infektiösen vogel-herpesvirus und rekombinante impfstoffe, die unter dessen verwendung hergestellt wurden
US6506385B1 (en) 1998-04-17 2003-01-14 Embrex, Inc. Live vaccines and methods of treatment therewith
US6299882B1 (en) * 1999-04-09 2001-10-09 Schering Corporation UL54.5 of Marek's disease virus (MDV)
CA2388822A1 (en) * 1999-10-29 2001-05-10 Human Genome Sciences, Inc. 27 human secreted proteins
US6516246B2 (en) * 2000-09-11 2003-02-04 Mimicking Man Manually, Inc. Method and system for determining native neurological dominant hemisphere
US7314715B2 (en) * 2001-06-14 2008-01-01 Schering-Plough Animal Health Corporation Recombinant avian herpesvirus useful in vaccine production
US6764684B2 (en) 2001-09-28 2004-07-20 Zeon Corporation Avian herpesvirus-based recombinant infectious bursal disease vaccine
WO2003100007A2 (en) 2002-05-24 2003-12-04 Schering-Plough Ltd. Eta-1 gene and methods for use
US20070003520A1 (en) 2003-11-17 2007-01-04 Brown Susanne M Mutant viruses
GB0326798D0 (en) 2003-11-17 2003-12-24 Crusade Lab Ltd Methods for generating mutant virus
US7897146B2 (en) 2003-11-17 2011-03-01 Crusade Laboratories Limited Treatment using herpes simplex virus
CA2603944C (en) * 2005-04-08 2015-06-23 Bayer Bioscience N.V. Elite event a2704-12 comprising the integration of the phosphinothricin acetyltransferase (pat) gene into soybeans, and methods and kits for identifying such event in biological samples
US20080241188A1 (en) 2007-03-30 2008-10-02 Zeon Corporation Turkey herpesvirus vectored recombinant containing avian influenza genes
BRPI0913216A2 (pt) * 2008-06-23 2016-01-19 Intervet Int Bv uso de um herpesvírus recombinante de perus, e, herpesvírus recombinante de perus.
US9089360B2 (en) 2008-08-06 2015-07-28 Ethicon Endo-Surgery, Inc. Devices and techniques for cutting and coagulating tissue
BR112014008161A2 (pt) * 2011-10-21 2017-04-11 Intervet Int Bv vírus da doença de marek não patogênico recombinante, método para a preparação do mesmo, molécula do ácido nucleico, célula hospedeira, vacina para aves domésticas, método para a preparação de uma vacina, uso de um vírus da doença de marek não patogênico recombinante, e, método de vacinação de aves domésticas
TR201818883T4 (tr) * 2011-10-21 2019-01-21 Intervet Int Bv Enfeksiyöz laringotrakeit virüsü ve Newcastle hastalığı virüsü antijenlerini kodlayan rekombinant patojenik olmayan marek hastalığı virüsü yapıları.
EP2644702A1 (en) 2012-03-30 2013-10-02 Ceva Sante Animale Multivalent recombinant avian herpes virus and vaccine for immunizing avian species
AR097029A1 (es) * 2013-07-26 2016-02-17 Intervet Int Bv Aceleración de la respuesta inmune inducida por virus vectorial en aves, composición, uso, método para la vacunación y método para acelerar la respuesta inmune
AR103245A1 (es) 2014-12-24 2017-04-26 Intervet Int Bv Vacuna vectorial basada en hvt (herpes virus de los pavos) frente a nd (enfermedad de newcastle) - ibd (enfermedad de gumboro) mejorada
EP3471766B1 (en) 2016-06-17 2022-12-14 Intervet International B.V. Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and infectious bursal disease virus antigens
KR20230170803A (ko) 2016-12-14 2023-12-19 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 조류 병원체의 다중 항원을 발현하는 재조합 hvt 벡터 및 그를 포함하는 백신
CN111542599A (zh) 2017-10-12 2020-08-14 英特维特国际股份有限公司 编码多种异源抗原的重组非致病性马尔克氏病病毒构建体
EP4028510A1 (en) 2019-09-11 2022-07-20 Zoetis Services LLC Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof
WO2021123104A1 (en) 2019-12-20 2021-06-24 Intervet International B.V. Multivalent hvt vector vaccine
BR112022025733A2 (pt) 2020-06-17 2023-03-07 Boehringer Ingelheim Vetmedica Gmbh Vetores hvt recombinantes expressando hemaglutinina de influenza e composições imunogênicas, e produção e usos dos mesmos
JP2024501943A (ja) 2020-12-24 2024-01-17 インターベット インターナショナル ベー． フェー． 多価ｈｖｔベクターワクチン
WO2023213946A1 (en) 2022-05-05 2023-11-09 Intervet International B.V. New multivalent hvt vector vaccine

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859587A (en) * 1984-06-04 1989-08-22 Institut Merieux Recombinant herpes simplex viruses, vaccines and methods
US5047237A (en) * 1985-09-06 1991-09-10 Prutech Research And Development Partnership Attenuated pseudorabies virus having a deletion of at least a portion of a gene encoding an antigenic, nonessential protein, vaccine containing same and methods of identifying animals vaccinated with the vaccine
US5928648A (en) * 1985-09-06 1999-07-27 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
US5223424A (en) * 1985-09-06 1993-06-29 Prutech Research And Development Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence
US4877737A (en) * 1985-09-06 1989-10-31 Prutech Research And Development Partnership Attenuated pseudorabies virus which has a deletion in at least a portion of a repeat sequence and vaccine containing same
AU619181B2 (en) * 1987-03-19 1992-01-23 Synergen, Inc. Viral vector system for the introduction of foreign dna expression products into gallinaceous birds
CA1337120C (en) * 1987-07-27 1995-09-26 Mark D. Cochran Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccines containing same
JP2583115B2 (ja) * 1988-09-10 1997-02-19 財団法人化学及血清療法研究所 組換えマレック病ウイルスおよびその製法
JP3292371B2 (ja) * 1988-09-13 2002-06-17 メリアル ウイルスのヌクレオチド配列
US5225336A (en) * 1989-03-08 1993-07-06 Health Research Incorporated Recombinant poxvirus host range selection system
EP0431668B1 (en) * 1989-12-04 1995-02-15 Akzo Nobel N.V. Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
FR2659349B1 (fr) * 1990-03-12 1993-12-24 Rhone Merieux Virus herpes recombinants notamment pour la realisation de vaccins, leur procede de preparation, les plasmides realises au cours de ce procede et les vaccins obtenus.
DE69101683T2 (de) * 1990-07-30 1994-07-21 Akzo Nv Rekombinantes Mareks-Krankheitsvirus.
US5252717A (en) * 1990-08-24 1993-10-12 Board Of Trustees Operating Michigan State University Marek's disease herpesvirus DNA segments encoding glycoproteins, gD, gI and gE
WO1992003554A1 (en) * 1990-08-24 1992-03-05 Arthur Webster Pty. Ltd. Infectious laryngotracheitis virus vaccine
FR2666589B1 (fr) * 1990-09-07 1994-08-05 Rhone Merieux Nouveaux virus herpes recombinants, vaccin a base de ces recombinants, leur procede de preparation, genes, vecteurs et plasmides utilises dans ce procede.
EP0486106A3 (en) * 1990-11-16 1992-12-23 Akzo N.V. Marek's disease virus vaccine
US5240703A (en) * 1991-03-01 1993-08-31 Syntro Corporation Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof
JP3602530B2 (ja) * 1991-03-07 2004-12-15 ヴァイロジェネティクス コーポレイション 遺伝子操作したワクチン菌株
US5853733A (en) * 1993-02-26 1998-12-29 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
FR2697534A1 (fr) * 1992-11-02 1994-05-06 Rhone Merieux Virus herpès de la dinde recombinant pour la réalisation de vaccin de la maladie de Gumboro, son procédé de préparation et vaccin obtenu.

Also Published As

Publication number Publication date
AU711815B2 (en) 1999-10-21
WO1996005291A1 (en) 1996-02-22
DE69536138D1 (de) 2011-03-24
AU3405395A (en) 1996-03-07
EP0776361A4 (en) 2003-06-04
JP4339835B2 (ja) 2009-10-07
ATE350467T1 (de) 2007-01-15
AU711815C (en) 2003-02-20
CA2196570A1 (en) 1996-02-22
US5965138A (en) 1999-10-12
EP0776361A1 (en) 1997-06-04
JP2006055171A (ja) 2006-03-02
JPH10506782A (ja) 1998-07-07
EP1801204B1 (en) 2011-02-09
ATE498006T1 (de) 2011-02-15
JP3756950B2 (ja) 2006-03-22
DE69535359T2 (de) 2007-10-11
DE69535359D1 (de) 2007-02-15
EP1801204A1 (en) 2007-06-27
ES2278382T3 (es) 2007-08-01
DK0776361T3 (da) 2007-04-30
CA2196570C (en) 2010-10-12
EP0776361B1 (en) 2007-01-03

Similar Documents

Publication Publication Date Title
MX9700833A (es) Virus de herpes recombinante de pavo y usos del mismo.
CA2660355A1 (en) Polynucleotide vaccine formulation against pathologies of the horse
CA2196555A1 (en) Vr-2332 viral nucleotide sequence and methods of use
AU585126B2 (en) Recombinant herpes simplex viruses, vaccines and methods
AU3472299A (en) Rna cancer vaccine and methods for its use
WO2000012127A3 (en) Dna cancer vaccine and methods for its use
HK32696A (en) Virus vaccine
WO2000003030A3 (en) Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species
WO1998037095A3 (en) Recombinant pox virus for immunization against muc1 tumor-associated antigen
HK1024931A1 (en) Recombinant swinepox virus
EP0256677A3 (en) Pseudorabies virus recombinants and their use in the production of proteins
DE69929530D1 (de) Attenuierte pferdeherpesvirus
AU4334193A (en) Infectious bovine rhinotracheitis virus mutants and vaccines
WO1997003187A3 (en) Marek's disease virus genes and their use in vaccines for protection against marek's disease
DK0606452T3 (da) Vektorvacciner fra rekombinant katteherpesvirus
DE122007000004I1 (de) Attenuierte Herpesviren, Herpesviren die eine Aminosäuresequenz kodierende fremde DNA enthalten, unddiese enthaltende Impfstoffe
AU686000B2 (en) Infectious peritonitis vaccine
ES2074965A1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
NZ511168A (en) Recombinant CELO virus and CELO virus DNA
MX9709514A (es) Viruses de fowlpox recombinantes y usos de los mismos.
WO2002010379B1 (en) Modified cea and uses thereof
Willemse et al. Recombinant feline herpesvirus vaccine
MY157873A (en) Recombinant mva virus, and the use thereof
PT99540A (pt) Processo para obtencao de virus de herpes recombinantes genes vectores e plasmidios utilizados nesse processo e processo para a preparacao de vacinas a base dos mencionados virus recombinantes
RU93056615A (ru) Вектор, способ получения вектора, способ получения лекарственного препарата, способ активизации иммунитета